Product categoriesMedical Treatment

Products 11 to 20 of 44

DNA Nanorobots by Wyss Institute + Harvard University
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 37,000,000 USD
Funding types: University + Government
Industry: Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Government
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/08/20 15:56 (3 years ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Health
Market status: Under Development
Organization type(s): Government
Product categories: Medical Treatment
Production process: Open Release
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Endocannabinoids for intestinal infection treatment by University of Texas Southwestern Medical Center
Biotech components: Molecule + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (1 year ago)
Date last modified: 2020/12/18 14:39 (1 year ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: Brazil + USA + India + Panama + Cayman Islands
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 26,132,305 GBP
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
EnLact Probiotics by ViThera Pharmaceuticals
Biotech components: Probiotic
Business models: B2C
Country of production: USA
Country of distribution: France + USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Epidiolex by EPIDIOLEX
Biotech components: N/A
Business models: B2B
Country of production: N/A
Country of distribution: USA
Intended consumer: Commercial + Consumer
Date added: 2019/04/01 10:02 (3 years ago)
Date last modified: 2019/04/12 09:32 (3 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Virus
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): University + Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Humanized Pig Organs by Synthetic Genomics + United Therapeutics’ Lung Biotechnology Inc
Biotech components: Animal
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/09/28 15:05 (4 years ago)
Known funding amount: 40,000,000 USD
Funding types: Venture Capital
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Enzyme
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 200,000,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: HALO (NASDAQ)
Value chain stage: Finished Product
Insulin-producing bacteria by Venter Institute
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/01 09:50 (4 years ago)
Known funding amount: 50,000 USD
Funding types: Foundation
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product